Q3 2022 Holdings
Filed 2022-11-14 | 71 holdings | $197.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Reata Pharmaceuticals Inc(RETAEUR) | Common Stocks | 75615P103 | $26.5K | 1,054,985 | 0.0% |
| Omnicell Inc(OMCL) | Common Stocks | 68213N109 | $30.4K | 349,106 | 0.0% |
| Krystal Biotech Inc(KRYS) | Common Stocks | 501147102 | $34.3K | 492,555 | 0.0% |
| Cutera Inc(CUTREUR) | Common Stocks | 232109108 | $34.8K | 763,180 | 0.0% |
| Si-Bone Inc(SIBN) | Common Stocks | 825704109 | $35.4K | 2,027,963 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | Common Stocks | 40637H109 | $36.9K | 932,244 | 0.0% |
| Karuna Therapeutics Inc | Common Stocks | 48576A100 | $37.4K | 166,316 | 0.0% |
| Seaspine Holdings Corp(SPNEUSD) | Common Stocks | 81255T108 | $40.1K | 7,067,572 | 0.0% |
| Model N Inc(MODNEUR) | Common Stocks | 607525102 | $89.3K | 2,608,221 | 0.0% |
| Prothena Corporation PLC(PRTA) | Common Stocks | G72800108 | $93.3K | 1,538,678 | 0.0% |
| Avantor Inc(AVTR) | Common Stocks | 05352A100 | $286.0K | 14,596 | 0.1% |
| Abbvie(ABBV) | Common Stocks | 00287Y109 | $502.0K | 3,740 | 0.3% |
| Castle Biosciences Inc(CSTL) | Common Stocks | 14843C105 | $4.3M | 163,224 | 2.2% |
| Caredx Inc(CDNA) | Common Stocks | 14167L103 | $9.4M | 549,797 | 4.7% |
| Bioventus Inc(BVS) | Common Stocks | 09075A108 | $9.8M | 1,398,922 | 5.0% |
| Biomarin Pharmaceutical Inc(BMRN) | Common Stocks | 09061G101 | $10.5M | 123,322 | 5.3% |
| Bicycle Therapeutics PLC(BCYC) | Common Stocks | 088786108 | $16.4M | 704,721 | 8.3% |
| Alphatec Holdings Inc(ATEC) | Common Stocks | 02081G201 | $26.0M | 2,974,658 | 13.2% |
| Crinetics Pharmaceuticals Inc(CRNX) | Common Stocks | 22663K107 | $26.4M | 1,346,652 | 13.4% |
| Axogen Inc(AXGN) | Common Stocks | 05463X106 | $34.7M | 2,911,824 | 17.6% |
| Atricure Inc(ATRC) | Common Stocks | 04963C209 | $58.4M | 1,494,655 | 29.6% |